Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShaftesbury Capital Regulatory News (SHC)

Share Price Information for Shaftesbury Capital (SHC)

Share Price is delayed by 15 minutes
Get Live Data
130.50    -2.50 (-1.88%)
Bid:
130.70
Ask:
130.90
Spread: 0.20 (0.153%)
Market Cap: £2.38b
SHC Live PriceLast checked at - London Stock Exchange

Intraday Shaftesbury Capital Share Chart

Bonds Redemption and Utilisation of Loan Facility

18 Apr 2023 12:45

RNS Number : 6195W
Shaftesbury Capital PLC
18 April 2023
 

 18 April 2023

SHAFTESBURY CAPITAL PLC

("The Group")

 

£290,000,000 SHAFTESBURY CHINATOWN PLC BONDS - 2.348 PER CENT. GUARANTEED FIRST MORTGAGE BONDS DUE 2027 - ISIN: XS1667074121, Common Code: 166707412(the "Chinatown Bonds")

and

£285,000,000 SHAFTESBURY CARNABY PLC BONDS - 2.487 PER CENT. GUARANTEED FIRST MORTGAGE BONDS DUE 2031 - ISIN: XS1493395070, Common Code: 149339507(the "Carnaby Bonds")

 

Guaranteed by

SHAFTESBURY PLC

 

Redemption of Bonds and Utilisation of Loan Facility

 

Following the occurrence of a change of control put event in respect of the Chinatown Bonds and the Carnaby Bonds (together, the "Bonds"), each bondholder had the option to require the relevant issuer to redeem (or, at the relevant issuer's option, purchase or procure the purchase of) its bonds by exercising a change of control put option by no later than 8 April 2023.

100 per cent. of the Chinatown Bond bondholders exercised their change of control put option and the Chinatown Bonds were redeemed in full on 17 April 2023 (the "Change of Control Put Date"). 99.9123 per cent. of the Carnaby Bond bondholders exercised their change of control put option and 99.9123 per cent. of the Carnaby Bonds were redeemed on the Change of Control Put Date.

On 18 April 2023, Shaftesbury Carnaby plc exercised its option to redeem the remaining outstanding Carnaby Bonds at their nominal amount, together with interest accrued to (but excluding) the date fixed for redemption, such date being 19 May 2023.

An application will be made to the Financial Conduct Authority to delist the Bonds following completion of the final redemption.

The redemption of the Bonds has been funded in full by utilisation of the Shaftesbury Capital PLC £576 million loan facility agreement provided by Barclays Bank PLC, BNP Paribas SA and HSBC Bank plc dated 16 June 2022 (the "Facility Agreement").

A summary of the Facility Agreement terms is set out in the merger prospectus dated 7 July 2022 and the Facility Agreement is available on the Shaftesbury Capital PLC website.

 

Enquiries:

Shaftesbury Capital PLC

 

Situl Jobanputra - Chief Financial OfficerGraham Keer - Group Treasurer

Desna Martin - Group Company Secretary

 

Telephone: +44 20 3214 9150

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAFLPFAPDEFA
Date   Source Headline
20th May 202611:30 amRNSDirector/PDMR Shareholding
15th May 20269:30 amRNSDirector/PDMR Shareholding
14th May 20263:30 pmRNSResult of AGM
14th May 20267:00 amRNSAGM Trading Update
30th Apr 20269:00 amRNSAdmission of shares and Total Voting Rights
22nd Apr 20261:30 pmRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSDirectorate change
9th Apr 20269:30 amRNS2025 Final Dividend - Exchange Rate
1st Apr 20269:00 amRNSAdditional Listing
27th Mar 202610:00 amRNSDirector/PDMR Shareholding
26th Mar 20262:00 pmRNSDirector/PDMR Shareholding
12th Mar 20262:45 pmRNSPublication of 2025 Annual Report and AGM Notice
25th Feb 20267:00 amRNSFinal Results
23rd Jan 20269:00 amRNSNotice of 2025 results
2nd Dec 20257:00 amRNSTrading Update
12th Nov 20257:00 amRNS-RManagement Update
27th Oct 202510:00 amRNSNon-executive Director Role Changes
17th Oct 20259:00 amRNSBlock listing Interim Review
7th Oct 202511:30 amRNSHolding(s) in Company
1st Oct 202510:00 amRNSNotice to Bondholders
24th Sep 20258:00 amRNSHolding(s) in Company
23rd Sep 20258:00 amRNSHolding(s) in Company
16th Sep 20254:00 pmRNSHolding(s) in Company
18th Aug 202512:00 pmRNSHolding(s) in Company
15th Aug 20259:00 amRNSHolding(s) in Company
12th Aug 20259:30 amRNS2025 Interim Dividend - Exchange Rate
30th Jul 20254:45 pmRNSNotice to Bondholders
29th Jul 20257:00 amRNSHalf-year Report
16th Jul 20253:30 pmRNSHolding(s) in Company
9th Jul 202510:30 amRNSHolding(s) in Company
4th Jul 20254:15 pmRNSHolding(s) in Company
1st Jul 20259:00 amRNSNotice of 2025 interim results
17th Jun 20259:30 amRNSHolding(s) in Company
30th May 202510:00 amRNSNotice to Bondholders
22nd May 20253:30 pmRNSResult of AGM
22nd May 20257:00 amRNSAGM Trading Update
21st May 202511:30 amRNSHolding(s) in Company
17th Apr 20259:00 amRNSBlock listing Interim Review
10th Apr 20259:30 amRNS2024 Final Dividend - Exchange Rate
1st Apr 202512:30 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSCompletion of transaction to form CG partnership
31st Mar 202512:00 pmRNSDirector/PDMR Shareholding
27th Mar 20252:00 pmRNSDirector/PDMR Shareholding
25th Mar 202511:00 amRNSNotification of new external appointment
20th Mar 20257:00 amRNSSHC and NBIM establish Covent Garden partnership
19th Mar 20256:09 pmRNSResponse to market speculation
13th Mar 20251:30 pmRNSPublication of 2024 Annual Report and AGM Notice
28th Feb 202512:00 pmRNSNotice to Bondholders
27th Feb 20257:00 amRNSFinal Results
27th Jan 20259:00 amRNSNotice of 2024 results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.